<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01015768</url>
  </required_header>
  <id_info>
    <org_study_id>08-10</org_study_id>
    <nct_id>NCT01015768</nct_id>
  </id_info>
  <brief_title>Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear</brief_title>
  <official_title>Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern California College of Optometry at Marshall B. Ketchum University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southern California College of Optometry at Marshall B. Ketchum University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess corneal staining and to measure the relative corneal&#xD;
      epithelial &quot;barrier&quot; function (the degree to which the cornea can prevent penetration of&#xD;
      colored sodium fluorescein dye into the eye) after 8 hours of wear with a known soft contact&#xD;
      lens and multipurpose lens care solution combination.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This investigation will evaluate corneal staining and epithelial barrier function after eight&#xD;
      hours of contact lens wear, which is past the peak staining time and more typical of daily&#xD;
      lens wear time. A silicone hydrogel lens and multipurpose solution combination shown to&#xD;
      induce significant corneal staining ( e.g. equivalent Grade 3 out of Grade 4 scale) will be&#xD;
      used to evaluate potential corneal compromise. The study will be a prospective,&#xD;
      single-center, double-masked, contralateral, daily wear investigation in adapted soft contact&#xD;
      lens wearers. After a three day washout period (without lens wear, lenses will then be worn&#xD;
      on one day for eight hours. Corneal staining and barrier function will be determined for a&#xD;
      regimen and a saline control situation for each subject. Staining will be graded using the&#xD;
      Efron Grading Scale, and permeability data will be estimated as the fluorescein penetration&#xD;
      rate, Pdc in nm/sec for the test and control condition.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Primary Outcome Measure Will be Corneal Epithelial Dye Diffusion Rate in Nanometers Per Second, for the Test and Control Eyes.</measure>
    <time_frame>After eight hours of wear</time_frame>
    <description>The fluorescein dye diffusion rate in nanometers per second, is a diffusion rate into the corneal tissue. The fluorescein dye diffuses from the tears, where it is in high concentration, into the cornea, where it is in low concentration. It's diffusion is limited (or not) by the barrier properties and health of the epithelium.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Permeability Rate, nm/Sec</measure>
    <time_frame>After eight hours of wear</time_frame>
    <description>A penetration rate, in nm/sec</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Secondary Outcome Measure Will be the Corneal Staining Grade, Compared Between the Test and Control Eye, as Well as Between the Baseline and Final Staining for Each Eye.</measure>
    <time_frame>After eight hours of wear</time_frame>
    <description>Corneal staining represents corneal abrasion or damage. It is graded by us on a 0 - 4 scale (4 being worst) in five corneal sectors. The total score per cornea or eye is thus graded on a 0 - 20 total scale.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Contact Lens-induced Corneal Fluorescein Staining</condition>
  <arm_group>
    <arm_group_label>Test eye</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Uses ReNu Multiplus as multipurpose soaking solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A new lens (PureVision) is soaked for 2 hours in non-preserved saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReNu Multiplus multipurpose disinfecting solution</intervention_name>
    <description>A new lens (PureVision) soaked 6 hours to overnight in ReNu Multiplus</description>
    <arm_group_label>Test eye</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>A new lens (PureVision) is soaked for two hours in non-preserved saline</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 18 years of age.&#xD;
&#xD;
          -  Understand your rights as a research subject and give written informed consent by&#xD;
             signing the Informed Consent Form, Subject Bill of Rights, and Patient Authorization&#xD;
             for Use and Release of Health and Research Study Information (HIPAA form).&#xD;
&#xD;
          -  Be likely to finish the entire study, understand the study instructions, and be&#xD;
             willing to follow the instructions.&#xD;
&#xD;
          -  Contact lens prescription between +4.00 D to -9.00 D (spherical equivalent).&#xD;
&#xD;
          -  Best correctable visual acuity of at least 20/40 in each eye.&#xD;
&#xD;
          -  Willing to de-adapt (do not wear) from habitual contact lenses for a period of at&#xD;
             least two days prior to eligibility visit and at least two days prior to the testing&#xD;
             day.&#xD;
&#xD;
          -  Possess a functional spectacle (eyeglass) prescription to allow adequate vision during&#xD;
             the de-adaptation and barrier function determination periods.&#xD;
&#xD;
          -  No known allergies, which may interfere with contact lens wear.&#xD;
&#xD;
          -  No known systemic (pertaining to general health) disease, or need for medication that&#xD;
             may interfere with contact lens wear (i.e. antihistamines, beta-blockers, steroids).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Less than one month successful, full time (defined as at least 8 hours per day, and&#xD;
             more than 5 days per week) soft lens wear.&#xD;
&#xD;
          -  Clinically significant corneal swelling (greater than grade 3 or 4 on a 0-4 scale),&#xD;
             corneal blood vessel growth (vascularization), corneal staining, bulbar redness,&#xD;
             tarsal redness, or any other abnormality of the cornea that may cause unsafe contact&#xD;
             lens wear.&#xD;
&#xD;
          -  Any active ocular infection.&#xD;
&#xD;
          -  Prior corneal refractive surgery (i.e., LASIK, PRK, etc).&#xD;
&#xD;
          -  Have used medications within 24 hours of study entry or have an ongoing need to use&#xD;
             ocular medication.&#xD;
&#xD;
          -  Are taking part in any other study or have taken part in a study within the last 14&#xD;
             days&#xD;
&#xD;
          -  Have a medical condition that your study eye doctor thinks may make it not appropriate&#xD;
             for you to participate in this study.&#xD;
&#xD;
          -  Are pregnant, or anticipate becoming pregnant during the course of this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerry R Paugh, OD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Southern California College of Optometry at Marshall B. Ketchum University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Southern California Colege of Optometry</name>
      <address>
        <city>Fullerton</city>
        <state>California</state>
        <zip>92831</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>November 16, 2009</study_first_submitted>
  <study_first_submitted_qc>November 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2009</study_first_posted>
  <results_first_submitted>July 19, 2011</results_first_submitted>
  <results_first_submitted_qc>August 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 18, 2020</results_first_posted>
  <last_update_submitted>August 27, 2020</last_update_submitted>
  <last_update_submitted_qc>August 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southern California College of Optometry at Marshall B. Ketchum University</investigator_affiliation>
    <investigator_full_name>Jerry R. Paugh, OD, PhD</investigator_full_name>
    <investigator_title>Professor, Associate Dean or Research</investigator_title>
  </responsible_party>
  <keyword>corneal staining</keyword>
  <keyword>barrier function</keyword>
  <keyword>contact lenses</keyword>
  <keyword>contact lens care solutions</keyword>
  <keyword>contact lens material and care solution bioincompatibility</keyword>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Eyes were randomized to one of two conditions.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Test Eye</title>
          <description>A new PureVision contact lens is soaked in ReNu Multiplus disinfecting solution and worn for 8 hours</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>A new PureVision contact lens is soaked in non-preserved saline and worn for 8 hours</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Some subject data unuseable</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Participants</title>
          <description>A new lens (PureVision) is soaked in ReNu Multiplus multipurpose soaking solution&#xD;
A new lens (PureVision) is soaked for 2 hours in non-preserved saline</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.2" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Permeability Rate, Pdc</title>
          <description>Diffusion rate in nanometers per second</description>
          <units>nanometers per second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.05749" spread="0.038"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Primary Outcome Measure Will be Corneal Epithelial Dye Diffusion Rate in Nanometers Per Second, for the Test and Control Eyes.</title>
        <description>The fluorescein dye diffusion rate in nanometers per second, is a diffusion rate into the corneal tissue. The fluorescein dye diffuses from the tears, where it is in high concentration, into the cornea, where it is in low concentration. It's diffusion is limited (or not) by the barrier properties and health of the epithelium.</description>
        <time_frame>After eight hours of wear</time_frame>
        <population>Analysis was per protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>PHMB-containing Disinfectant</title>
            <description>New lens soaked in B&amp;L ReNu Multiplus disinfecting solution.</description>
          </group>
          <group group_id="O2">
            <title>Non-preserved Saline</title>
            <description>New lens soaked for two hours in non-preserved saline</description>
          </group>
        </group_list>
        <measure>
          <title>The Primary Outcome Measure Will be Corneal Epithelial Dye Diffusion Rate in Nanometers Per Second, for the Test and Control Eyes.</title>
          <description>The fluorescein dye diffusion rate in nanometers per second, is a diffusion rate into the corneal tissue. The fluorescein dye diffuses from the tears, where it is in high concentration, into the cornea, where it is in low concentration. It's diffusion is limited (or not) by the barrier properties and health of the epithelium.</description>
          <population>Analysis was per protocol.</population>
          <units>nanometers per second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0567" spread="0.039"/>
                    <measurement group_id="O2" value="0.0583" spread="0.038"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Permeability Rate, nm/Sec</title>
        <description>A penetration rate, in nm/sec</description>
        <time_frame>After eight hours of wear</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Test Eye</title>
            <description>Uses ReNu Multiplus as multipurpose soaking solution</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>A new lens (PureVision) is soaked for 2 hours in non-preserved saline</description>
          </group>
        </group_list>
        <measure>
          <title>Permeability Rate, nm/Sec</title>
          <description>A penetration rate, in nm/sec</description>
          <units>nm/sec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.057" spread="0.04"/>
                    <measurement group_id="O2" value="0.058" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Secondary Outcome Measure Will be the Corneal Staining Grade, Compared Between the Test and Control Eye, as Well as Between the Baseline and Final Staining for Each Eye.</title>
        <description>Corneal staining represents corneal abrasion or damage. It is graded by us on a 0 - 4 scale (4 being worst) in five corneal sectors. The total score per cornea or eye is thus graded on a 0 - 20 total scale.</description>
        <time_frame>After eight hours of wear</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PHMB-containing Disinfectant</title>
            <description>New lens soaked in B&amp;L ReNu Multiplus disinfecting solution.</description>
          </group>
          <group group_id="O2">
            <title>Non-preserved Saline</title>
            <description>New lens soaked for two hours in non-preserved saline</description>
          </group>
        </group_list>
        <measure>
          <title>The Secondary Outcome Measure Will be the Corneal Staining Grade, Compared Between the Test and Control Eye, as Well as Between the Baseline and Final Staining for Each Eye.</title>
          <description>Corneal staining represents corneal abrasion or damage. It is graded by us on a 0 - 4 scale (4 being worst) in five corneal sectors. The total score per cornea or eye is thus graded on a 0 - 20 total scale.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.95" spread="2.4"/>
                    <measurement group_id="O2" value="4.52" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Test Eye</title>
          <description>Uses ReNu Multiplus as multipurpose soaking solution</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>A new lens (PureVision) is soaked for 2 hours in non-preserved saline</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No limitations</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Jerry R. Paugh, OD, PhD</name_or_title>
      <organization>Southern California College of Optometry</organization>
      <phone>714-449-7487</phone>
      <email>jpaugh@scco.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

